Chlormezanone

氯美扎酮

Report date: 2023/01/13 20:00:32
NME

Base Information

Drug NameChlormezanone
Drug Alias Name氯嗪酮Chlormezanonum氯甲噻酮Clormezanona氯美乍酮 +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTranslocator protein stimulants
TargetsTranslocator protein
Therapy Area/IndicationsAnxiety DisordersSleep Initiation and Maintenance DisordersMuscle Spasticity
Global Approved IndicationsAnxiety DisordersSleep Initiation and Maintenance DisordersMuscle Spasticity
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi-Aventis U.S. Llc
Active IndicationsN/A
Inactive IndicationsAnxiety DisordersSleep Initiation and Maintenance DisordersMuscle Spasticity

Other Information

ATC CodeM03BB02
Related LinksWikipediaDrugBankKEGG